STAT Plus: Gilead challenges U.S. government patents on a controversial HIV prevention pill
ERIC RISBERG/AP
The drug maker claims that four patents held by the federal government for using the Truvada pill to prevent HIV are not valid.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario